PSA Response as a Prognostic Factor of Overall Survival in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Real-world Evidence

Authors: Ana Guijarro, Estíbaliz Jiménez, Antoni Vilaseca et al.
Publication: European Urology Open Science
Published: Jun 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Corporate Social Responsibility: A marketing tool and/or a factor for the promotion of sustainable development for companies? An empirical examination of listed companies in the Athens Stock Exchange

Olga Helen Astara, Roldo Mitoula et al. - Apr 2115

Read More
Market Failure or Government Failure? A Response to Jaworski

Joseph Heath - Mar 2103

Read More
Sparsity Learning via Structured Functional Factor Augmentation

Hanteng Ma, Ziliang Shen et al. - Jan 2029

Read More
Optimal Response-Free Cluster Subsampling for Longitudinal Data Under Measurement Constrains

Junhao Shan, Lei Wang et al. - Jan 2029

Read More
Cyber Defense Digital Twins: A Federated Learning and Zero-Trust AI Architecture for Autonomous Threat Prediction and Response

Sivaramakrishnan Narayanan - Aug 2028

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Center Research Guides Citescore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0